Therapeutic Advances in Drug Safety
@TADrugSafety
Followers
645
Following
822
Media
182
Statuses
1K
Drug safety and pharmacovigilance💊 | Impact Factor: 4.4 | Indexing: SCIE, PMC, WoS, Scopus | Launched in 2011 📖 | Published by @SAGEJournals | #OpenAccess
SAGE Publishing
Joined January 2019
📣TADS is recruiting!. Perfect for early and mid career researchers, join our new Editorial Reviewer Board to make an impact in the Drug Safety field. 🔸Read more: 🔸Apply here: #DrugSafety #PeerReview #OpenAccess
0
1
3
The third session on practical implementations of #ArtificialInteligence provided us with insights from both academic and industry perspectives. #pharmacovigilance #PatientSafety #DrugSafety #EUPV2024.
0
0
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
396
661
3K
Congratulations to @alqenaie for being awarded best article published in TADS in 2023 during #EUPV2024!. Very well-deserved for her article the nature and contributory factors of #MedicationSafety incidents following hospital discharge. Read more here:
journals.sagepub.com
Introduction: Improving medication safety during transition of care is an international healthcare priority. While existing research reveals that medication-rel...
Honoured to be the recipient of the European Pharmacovigilance Congress 2024 Award #EUPV2024 🏆 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐛𝐞𝐬𝐭 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 published in the Therapeutic Advances in Drug Safety Journal @TADrugSafety in 2023! . Research team: @RichardKeers @ACarsonStevens @doug_steinke
1
1
4
0
2
0
An insightful and thought-provoking session of a range of talks about both global and local #pharmacovigilance updates, including updates on good clinical practice and how AI is informing regulatory intelligence. #EUPV2024 #pharmacovigilance #DrugSafety.
0
0
0
#EUPV2024 has kicked off with strong morning sessions focusing on an industry perspective on evolving #pharmacovigilance strategies. Interesting takes on aspirational #AI use in PV, such as #ClinicalTrial optimisation/simulation and processing individual case safety reports.
0
0
0
The Managing Editor of TADS is at #EUPV2024 in Milano! Stop by our table and say hello 👋. #pharmacovigilance #DrugSafety #PatientSafety #pharmacology #OpenAccess
0
0
0
RT @TARespirDis: Exciting news!📢 . Discover our first PLS-P (plain language summary of publication) detailing findings from a clinical stud….
journals.sagepub.com
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2...
0
2
0
Now open for submissions!. An exciting new special collection on #ArtificialIntelligence and #MachineLearning in #pharmacovigilance with Andrew Bate and Phil Tregunno as Guest Editors. For more information, please visit the link below: .
0
0
1
New research in TADS 💡. Roth et al. analyzed 521 #quetiapine prescriptions and found that 67% of them were inappropriate for the patient, leading to excess costs and compromised #PatientSafety. Learn more below: #Pharmacovigilance #DrugSafety
0
2
2
RT @TADrugSafety: 📣TADS is recruiting!. Perfect for early and mid career researchers, join our new Editorial Reviewer Board to make an impa….
0
1
0
This innovative role will facilitate the flow of information and help to combat challenges often faced by MAHs, such as fully achieving mapping of local requirements to fulfil regulatory compliance and maintaining oversight.
0
0
0
Lucia Biagiotti, Pharma D&S, discusses the creation of a new role - Local Safety Officer Coordinators. This role will act as a bridge between local drug safety activities and MAH/EU QPPV authorities. #DrugSafety #EUPV #EUPV2023.
1
0
0
A very important topic with many moving parts - all of which are key to ensuring a high standard of Pharmacovigilance requirements are consistently met.
0
0
0
Laura Boga from Dompé farmaceutici S.p.A. begins our final session by discussing the implications of the expansion of pharmaceutical companies and how this impacts #pharmacovigilance. #EUPV2023 #EUPV #DrugSafety.
1
0
0
Key topics of discussion included:.🔹The biggest challenges they have experienced and how they overcame them, such as navigating urgent and unannounced inspections.🔹Management and review of the PSMF.🔹How inspections differ globally.
0
0
0
This session is rounded off by fruitful discussions with a wonderful panel and a remote call-in with experts Tea Babić, Raj Bhogal, and Charalampos Nakos to further discuss the dynamics of #DrugInspections from different perspectives. #DrugSafety #DrugRegulation #EUPV2023 #EUPV.
1
0
0
Tea Babić from Teva Pharmaceuticals talks about her work surrounding #DrugInspections and their processes, while also touching on notable inspection trends from all around the globe. #EUPV2023 #EUPV #Pharmacovigilance #DrugSafety.
0
0
0
Very nicely broken down into the history of the Brazilian Health Regulatory Agency, an explanation of the Brazilian healthcare system, #DrugInspection steps and classification systems, and future aims and goals.
0
0
0
Monica de luz Carvalho Soares from the Brazilian Health Regulatory Agency, Anvisa, provides us with an update on #pharmacovigilance advances in Brazil. #EUPV2023 #EUPV #DrugSafety.
1
0
0